Dosimetric Evaluation of Hippocampus Sparing Intensity Modulated Radiation Therapy in Patients with Stage T1-T2 and Stage T3-T4 Nasopharyngeal Carcinoma
Xiaofeng Zhou,Kui Wu,Niharika Prasad,Sanjay Jaiswal,Biao Jiang,Xia Li,Wenzheng Sun,Lingli Mao,Kanghua Huang,Minghan Shi,Shen Li,Qichun Wei
DOI: https://doi.org/10.1016/j.adro.2024.101646
2024-01-01
Advances in Radiation Oncology
Abstract:Purpose: To compare the hippocampus (HPC) dose reduced by HPC-sparing intensity modulated radiation therapy (IMRT) plans between nasopharyngeal carcinoma (NPC) patients of stages T1-T2 and T3-T4, and to investigate the correlation between the dose of the HPC and the volume of PTVnx70 (the planning target volume of the primary tumor in the nasopharynx that received 70 Gy). Methods and Materials: Fifty-eight NPC patients were retrospectively evaluated. HPC-nonsparing IMRT or sparing IMRT for each patient was designed according to the protocol for NPC. Dose-volume histogram was used to evaluate the IMRT plans for each patient. The difference in values of HPC parameters (eg, D-min[NS] - D-min[S]) between HPC-sparing and nonsparing plans in the stage T1-T2 group and stage T3-T4 group were compared. The correlations between the dose of the HPC and the volume of PTVnx70 were analyzed. Results: There was no significance between HPC-sparing and nonsparing IMRT plans. Compared with the HPC-nonsparing plans, the HPC-sparing plans significantly decreased both dosimetric and volumetric parameters for the HPC (P < .05), except for D-min, D-98%,D- and V-5. The medians of D-median[NS] - D-median[S], D-mean[NS] - D-mean[S], D-40%[NS] - D-40%[S], V-30[NS] - V-30[S], V-40[NS] - V-40[S] and V-50[NS] - V-50[S] in the T1-T2 group were significantly lower than in the T3-T4 group (P < .05), respectively. Both dosimetric and volumetric parameters for the HPC were positively correlated with the volume of PTVnx70 in HPC-sparing and HPC-nonsparing plans (P < .05). The volume of PTVnx70 was positively correlated with D-median[NS] - D-median[S], D-mean[NS] - D-mean[S], D-40%[NS] - D-40%[S], V-40[NS] - V-40[S] and V-50[NS] - V-50[S] (P < .05). Conclusions: HPC-sparing IMRT plans may play a more significant role in decreasing D-median, D-mean, D-40%,D- and V-30-V-50 of HPC in NPC patients with stages T3-T4 than those in stages T1-T2. PTVnx70 volume of NPC patients is positively correlated with all dosimetric and volumetric parameters of HPC and the reduction of specific dosage parameters by HPC-sparing IMRT plans. (c) 2024 Published by Elsevier Inc. on behalf of American Society for Radiation Oncology. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).